Showing results (1301-1310 of 6,882) with videos related to
Sort By:
Pageof 689
Leukemia Research|October 31, 2013
Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplificationsMohammad Bahmanyar, Xiaoying Qi, Hong ChangLeukemia Research|November 27, 2012
Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myelomaPhilippe Moreau, Sergio A GiraltLeukemia Research|November 27, 2012
How to maintain patients on long-term therapy: understanding the profile and kinetics of adverse eventsMaría-Victoria MateosLeukemia Research|November 28, 2012
Birth weight in offspring and leukaemia risk in parents--a nation-wide register-based cohort study from DenmarkMaria Marklund, Klaus Rostgaard, Lisa Hjalgrim, et al.Leukemia Research|October 16, 2013
CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatmentHongju Zhang, Guoqiang Chang, Jian Wang, et al.Leukemia Research|October 22, 2013
A phase I study of decitabine and rapamycin in relapsed/refractory AMLJane L Liesveld, Kristen O'Dwyer, Alison Walker, et al.Leukemia Research|November 28, 2013
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemiaConcetta Quintarelli, Biagio De Angelis, Santa Errichiello, et al.Leukemia Research|November 20, 2013
Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: a prospective analysisMartin Brejcha, Martina Stoklasová, Yvona Brychtová, et al.Leukemia Research|January 1, 1986
Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cellsG G Chabot, R L MomparlerLeukemia Research|November 19, 2013
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 studyArnon P Kater, Marjolein Spiering, Roberto D Liu, et al.Pageof 689